Say goodbye to the $1,000 genome, and even the $100 genome. Thanks to the lab of physicist David Weitz, PhD, at Harvard University, there may now be an even lower benchmark for the viable future. Speaking on June 2 at the Second Annual Consumer Genetics Conference in Boston, Weitz told the audience he has developed technology for doing whole-genome sequencing for as little as $30 a pop – a price point quickly adopted by several subsequent panel moderators and speakers as a new reference standard by the meeting's end.
If that objective sounds ambitious, it is – especially since the fledgling company Weitz has established to pursue this, GnuBio,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?